Report Detail

Pharma & Healthcare Global Antifungal Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3369553
  • |
  • 01 May, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Scope of the Report:
The worldwide market for Antifungal Drugs is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antifungal Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Bayer Healthcare
Sanofi-Aventis
Novartis
Pfizer Inc.
Abbott Laboratories
Merck & Co. Inc.
GlaxoSmithKline
ID Sigma-Aldrich Corporation
Astellas Pharma Inc
Glenmark Pharmaceuticals Ltd
Enzon Pharmaceuticals
SRS Pharmaceuticals Pvt. Ltd.
Naman Pharma Drugs

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Azoles
Echinocandins
Polyenes
Allyamines

Market Segment by Applications, can be divided into
Dermatophytosis
Aspergillosis
Candidiasis

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antifungal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antifungal Drugs, with price, sales, revenue and global market share of Antifungal Drugs in 2017 and 2018.
Chapter 3, the Antifungal Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antifungal Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antifungal Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antifungal Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Antifungal Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Azoles
      • 1.2.2 Echinocandins
      • 1.2.3 Polyenes
      • 1.2.4 Allyamines
    • 1.3 Market Analysis by Applications
      • 1.3.1 Dermatophytosis
      • 1.3.2 Aspergillosis
      • 1.3.3 Candidiasis
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bayer Healthcare
      • 2.1.1 Business Overview
      • 2.1.2 Antifungal Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Bayer Healthcare Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi-Aventis
      • 2.2.1 Business Overview
      • 2.2.2 Antifungal Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi-Aventis Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Novartis
      • 2.3.1 Business Overview
      • 2.3.2 Antifungal Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Novartis Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Pfizer Inc.
      • 2.4.1 Business Overview
      • 2.4.2 Antifungal Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Pfizer Inc. Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Abbott Laboratories
      • 2.5.1 Business Overview
      • 2.5.2 Antifungal Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Abbott Laboratories Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Merck & Co. Inc.
      • 2.6.1 Business Overview
      • 2.6.2 Antifungal Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Merck & Co. Inc. Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 GlaxoSmithKline
      • 2.7.1 Business Overview
      • 2.7.2 Antifungal Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 GlaxoSmithKline Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 ID Sigma-Aldrich Corporation
      • 2.8.1 Business Overview
      • 2.8.2 Antifungal Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 ID Sigma-Aldrich Corporation Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Astellas Pharma Inc
      • 2.9.1 Business Overview
      • 2.9.2 Antifungal Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Astellas Pharma Inc Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Glenmark Pharmaceuticals Ltd
      • 2.10.1 Business Overview
      • 2.10.2 Antifungal Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Glenmark Pharmaceuticals Ltd Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Enzon Pharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 Antifungal Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Enzon Pharmaceuticals Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 SRS Pharmaceuticals Pvt. Ltd.
      • 2.12.1 Business Overview
      • 2.12.2 Antifungal Drugs Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 SRS Pharmaceuticals Pvt. Ltd. Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Naman Pharma Drugs
      • 2.13.1 Business Overview
      • 2.13.2 Antifungal Drugs Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Naman Pharma Drugs Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Antifungal Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Antifungal Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Antifungal Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Antifungal Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Antifungal Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Antifungal Drugs Market Analysis by Regions

    • 4.1 Global Antifungal Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Antifungal Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Antifungal Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Antifungal Drugs Sales and Growth Rate (2014-2019)

    5 North America Antifungal Drugs by Country

    • 5.1 North America Antifungal Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Antifungal Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Antifungal Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Antifungal Drugs Sales and Growth Rate (2014-2019)

    6 Europe Antifungal Drugs by Country

    • 6.1 Europe Antifungal Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Antifungal Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Antifungal Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Antifungal Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Antifungal Drugs by Country

    • 7.1 Asia-Pacific Antifungal Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Antifungal Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Antifungal Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Antifungal Drugs Sales and Growth Rate (2014-2019)

    8 South America Antifungal Drugs by Country

    • 8.1 South America Antifungal Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Antifungal Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Antifungal Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Antifungal Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Antifungal Drugs by Countries

    • 9.1 Middle East and Africa Antifungal Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Antifungal Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Antifungal Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Antifungal Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Antifungal Drugs Sales and Growth Rate (2014-2019)

    10 Global Antifungal Drugs Market Segment by Type

    • 10.1 Global Antifungal Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Antifungal Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Antifungal Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Azoles Sales Growth and Price
      • 10.2.1 Global Azoles Sales Growth (2014-2019)
      • 10.2.2 Global Azoles Price (2014-2019)
    • 10.3 Echinocandins Sales Growth and Price
      • 10.3.1 Global Echinocandins Sales Growth (2014-2019)
      • 10.3.2 Global Echinocandins Price (2014-2019)
    • 10.4 Polyenes Sales Growth and Price
      • 10.4.1 Global Polyenes Sales Growth (2014-2019)
      • 10.4.2 Global Polyenes Price (2014-2019)
    • 10.5 Allyamines Sales Growth and Price
      • 10.5.1 Global Allyamines Sales Growth (2014-2019)
      • 10.5.2 Global Allyamines Price (2014-2019)

    11 Global Antifungal Drugs Market Segment by Application

    • 11.1 Global Antifungal Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Dermatophytosis Sales Growth (2014-2019)
    • 11.3 Aspergillosis Sales Growth (2014-2019)
    • 11.4 Candidiasis Sales Growth (2014-2019)

    12 Antifungal Drugs Market Forecast (2019-2024)

    • 12.1 Global Antifungal Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Antifungal Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Antifungal Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Antifungal Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Antifungal Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Antifungal Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Antifungal Drugs Market Forecast (2019-2024)
    • 12.3 Antifungal Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Antifungal Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Antifungal Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Antifungal Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Antifungal Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Antifungal Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Antifungal Drugs. Industry analysis & Market Report on Antifungal Drugs is a syndicated market report, published as Global Antifungal Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Antifungal Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,735.28
      4,102.92
      5,470.56
      3,215.52
      4,823.28
      6,431.04
      544,898.40
      817,347.60
      1,089,796.80
      289,849.20
      434,773.80
      579,698.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report